标题
Production and Application of CAR T Cells: Current and Future Role of Europe
作者
关键词
-
出版物
Frontiers in Medicine
Volume 8, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2021-08-16
DOI
10.3389/fmed.2021.713401
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- The long road to the first FDA-approved gene therapy: chimeric antigen receptor T cells targeting CD19
- (2020) Peter Braendstrup et al. CYTOTHERAPY
- Toward an Optimized Process for Clinical Manufacturing of CAR-Treg Cell Therapy
- (2020) Enrico Fritsche et al. TRENDS IN BIOTECHNOLOGY
- Point-Of-Care CAR T-Cell Production (ARI-0001) Using a Closed Semi-automatic Bioreactor: Experience From an Academic Phase I Clinical Trial
- (2020) Maria Castella et al. Frontiers in Immunology
- Demonstrating the Manufacture of Human CAR‐T Cells in an Automated Stirred‐Tank Bioreactor
- (2020) Elena Costariol et al. Biotechnology Journal
- Automated Manufacture of Autologous CD19 CAR-T Cells for Treatment of Non-hodgkin Lymphoma
- (2020) Zachary Jackson et al. Frontiers in Immunology
- The Landscape of CAR-T Cell Clinical Trials against Solid Tumors—A Comprehensive Overview
- (2020) Niels Schaft Cancers
- Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immune effector cell-related adverse events
- (2020) Marcela V Maus et al. Journal for ImmunoTherapy of Cancer
- Prise en charge pratique du syndrome de relargage des cytokines (CRS) post-CAR-T cells chez l’adulte et l’enfant : recommandation de la Société francophone de greffe de moelle et de thérapie cellulaire (SFGM-TC)
- (2019) Ibrahim Yakoub-Agha et al. BULLETIN DU CANCER
- Manufacturing chimeric antigen receptor T cells: issues and challenges
- (2019) Claire Roddie et al. CYTOTHERAPY
- Manufacturing and preclinical validation of CAR T cells targeting ICAM-1 for advanced thyroid cancer therapy
- (2019) Yogindra Vedvyas et al. Scientific Reports
- Towards Automated Manufacturing for Cell Therapies
- (2019) David Smith et al. Current Hematologic Malignancy Reports
- Automation in cell and gene therapy manufacturing: from past to future
- (2019) P. Moutsatsou et al. BIOTECHNOLOGY LETTERS
- Management of adults and children undergoing CAR t-cell therapy: best practice recommendations of the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE)
- (2019) Ibrahim Yakoub-Agha et al. HAEMATOLOGICA
- GMP-Compliant Manufacturing of NKG2D CAR Memory T Cells Using CliniMACS Prodigy
- (2019) Lucía Fernández et al. Frontiers in Immunology
- A Modified Post-Transplant Cyclophosphamide Regimen, for Unmanipulated Haploidentical Marrow Transplantation, in Acute Myeloid Leukemia: A Multicenter Study
- (2018) Patrizia Chiusolo et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Induction of a central memory and stem cell memory phenotype in functionally active CD4+ and CD8+ CAR T cells produced in an automated good manufacturing practice system for the treatment of CD19+ acute lymphoblastic leukemia
- (2018) Franziska Blaeschke et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- A guide to manufacturing CAR T cell therapies
- (2018) Philipp Vormittag et al. CURRENT OPINION IN BIOTECHNOLOGY
- Closed-system manufacturing of CD19 and dual-targeted CD20/19 chimeric antigen receptor T cells using the CliniMACS Prodigy device at an academic medical center
- (2018) Fenlu Zhu et al. CYTOTHERAPY
- Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia
- (2018) Shannon L. Maude et al. NEW ENGLAND JOURNAL OF MEDICINE
- ASBMT Consensus Grading for Cytokine Release Syndrome and Neurological Toxicity Associated with Immune Effector Cells
- (2018) Daniel W Lee et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Tisagenlecleucel in Adult Relapsed or Refractory Diffuse Large B-Cell Lymphoma
- (2018) Stephen J. Schuster et al. NEW ENGLAND JOURNAL OF MEDICINE
- Characterization of clinical grade CD19 chimeric antigen receptor T cells produced using automated CliniMACS prodigy system
- (2018) Wei Zhang et al. Drug Design Development and Therapy
- Driving CARs on the Highway to Solid Cancer: Some Considerations on the Adoptive Therapy with CAR T Cells
- (2017) Hinrich Abken HUMAN GENE THERAPY
- Automated Manufacturing of Potent CD20-Directed Chimeric Antigen Receptor T Cells for Clinical Use
- (2017) Dominik Lock et al. HUMAN GENE THERAPY
- Chimeric Antigen Receptor T Cells in Refractory B-Cell Lymphomas
- (2017) Stephen J. Schuster et al. NEW ENGLAND JOURNAL OF MEDICINE
- Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma
- (2017) Sattva S. Neelapu et al. NEW ENGLAND JOURNAL OF MEDICINE
- FDA Approves Second CAR T-cell Therapy
- (2017) Cancer Discovery
- First-Ever CAR T-cell Therapy Approved in U.S.
- (2017) Cancer Discovery
- Retargeting of UniCAR T cells with an in vivo synthesized target module directed against CD19 positive tumor cells
- (2017) Dominik Bachmann et al. Oncotarget
- Bioengineering Solutions for Manufacturing Challenges in CAR T Cells
- (2017) Nicole J. Piscopo et al. Biotechnology Journal
- Automated manufacturing of chimeric antigen receptor T cells for adoptive immunotherapy using CliniMACS Prodigy
- (2016) Ulrike Mock et al. CYTOTHERAPY
- Automated Enrichment, Transduction, and Expansion of Clinical-Scale CD62L+T Cells for Manufacturing of Gene Therapy Medicinal Products
- (2016) Christoph Priesner et al. HUMAN GENE THERAPY
- Towards a commercial process for the manufacture of genetically modified T cells for therapy
- (2015) A D Kaiser et al. CANCER GENE THERAPY
- Activated T cells armed with bispecific antibodies kill tumor targets
- (2015) Divaya Bhutani et al. CURRENT OPINION IN HEMATOLOGY
- Safety and activity of blinatumomab for adult patients with relapsed or refractory B-precursor acute lymphoblastic leukaemia: a multicentre, single-arm, phase 2 study
- (2015) Max S Topp et al. LANCET ONCOLOGY
- Chimeric antigen receptor T cells persist and induce sustained remissions in relapsed refractory chronic lymphocytic leukemia
- (2015) David L. Porter et al. Science Translational Medicine
- One million haemopoietic stem-cell transplants: a retrospective observational study
- (2015) Alois Gratwohl et al. Lancet Haematology
- Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia
- (2014) Shannon L. Maude et al. NEW ENGLAND JOURNAL OF MEDICINE
- Targeting T cells to tumor cells using bispecific antibodies
- (2013) Stanley R Frankel et al. CURRENT OPINION IN CHEMICAL BIOLOGY
- Chimeric Antigen Receptor–Modified T Cells for Acute Lymphoid Leukemia
- (2013) Stephan A. Grupp et al. NEW ENGLAND JOURNAL OF MEDICINE
- CAR T cells transform to trucks: chimeric antigen receptor–redirected T cells engineered to deliver inducible IL-12 modulate the tumour stroma to combat cancer
- (2012) Markus Chmielewski et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Chimeric Antigen Receptor–Modified T Cells in Chronic Lymphoid Leukemia
- (2011) David L. Porter et al. NEW ENGLAND JOURNAL OF MEDICINE
- T Cells with Chimeric Antigen Receptors Have Potent Antitumor Effects and Can Establish Memory in Patients with Advanced Leukemia
- (2011) M. Kalos et al. Science Translational Medicine
- Eradication of B-lineage cells and regression of lymphoma in a patient treated with autologous T cells genetically engineered to recognize CD19
- (2010) J. N. Kochenderfer et al. BLOOD
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now